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Abstract
Introduction: Although many in vitro and animal studies have demonstrated a protective effect of green tea
against breast cancer, findings from epidemiological studies have been inconsistent, and whether high green tea
intake reduces the risk of breast cancer remains unclear.
Methods: In this Japan Public Health Center-based Prospective Study, 581 cases of breast cancer were newly
diagnosed in 53,793 women during 13.6 years’ follow-up from the baseline survey in 1990 to 1994. After the five-
year follow-up survey in 1995 to 1998, 350 cases were newly diagnosed in 43,639 women during 9.5 years’ follow-
up. The baseline questionnaire assessed the frequency of total green tea drinking while the five-year follow-up
questionnaire assessed that of two types of green tea, Sencha and Bancha/Genmaicha, separately.
Results: Compared with women who drank less than one cup of green tea per week, the adjusted hazard ratio
(HR) for women who drank five or more cups per day was 1.12 (95% confidence interval (CI) 0.81 to 1.56; P for
trend = 0.60) in the baseline data. Similarly, compared with women who drank less than one cup of Sencha or
Bancha/Genmaicha per week, adjusted HRs for women who drank 10 or more cups per day were 1.02 (95% CI 0.55
to 1.89; P for trend = 0.48) for Sencha and 0.86 (0.34 to 2.17; P for trend = 0.66) for Bancha/Genmaicha. No inverse
association was found regardless of hormone receptor-defined subtype or menopausal status.
Conclusions: In this population-based prospective cohort study in Japan we found no association between green
tea drinking and risk of breast cancer.
Introduction
Green tea is regularly consumed in Japan and China as a
traditional habit and cultural characteristic. Although
produced from the same plant, Camellia sinensis, differ-
ences in the manufacturing process mean that green tea
has a higher catechin content than black tea [1-3],
which might contribute to its beneficial effects on can-
cer as well as cardiovascular diseases, and other condi-
tions [3,4]. Specifically, (-)-epigallocatechin-3-gallate
(EGCG), the most abundant and biologically active cate-
chin in green tea, might play an important role in can-
cer prevention [1-3,5,6]. Because breast cancer risk is
substantially lower in Asian than Western countries [7],
a contribution of high green tea intake to low breast
cancer risk has been hypothesized. This hypothesis has
been supported by in vitro and animal studies, which
have demonstrated various protective effects of green
tea and tea polyphenols acting via strong antioxidant
activity, inhibition of cell proliferation and angiogenesis,
induction of apoptosis, and antiestrogenic properties
[1-3,5,6,8].
In contrast to in vitro and animal studies, few epide-
miological studies have examined the association
between green tea intake and risk of breast cancer, and
their findings have been inconsistent [9-16]. An inverse
association was found in three case-control studies
among Asian-American and Chinese populations [9-11],
whereas no association was observed in two cohort
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in Singapore [14]. This inconsistency might be in part
explained by differences in study design and exposure
variation. In the three case-control studies which
reported an inverse association, the reference groups
were non-green tea drinkers, which included approxi-
mately 36 to 68% of control subjects [9-11], whereas in
the two Japanese cohort studies the reference groups
were women who drank less than one cup per day or
one or fewer cups per day [12,13]. Inclusion of green
tea drinkers in the reference group might attenuate the
difference in risk between the reference and the higher
drinking groups. Moreover, the highest consumption
group in the two Japanese cohort studies were women
who drank five or more cups per day, which included a
relatively large portion of subjects (approximately 26 to
43%) [12,13]. Several studies have suggested a possible
protective effect of very large amounts of green tea
intake: one case-control study in Japan showed a
decreased risk of gastric cancer among those who drank
10 or more cups per day [17], for example, while a
cohort study in Japan observed a decreased risk of can-
cer in all sites among those who drank 10 or more cups
per day [18]. However, a better understanding of the
role of green tea in the etiology of breast cancer would
be obtained from studies which included non- to heavy
green tea drinkers. In addition, given that in vitro stu-
dies have suggested the inhibition of aromatase by green
tea extracts [8] and of estrogen binding with its receptor
by EGCG [6], the effect of green tea intake on the risk
of breast cancer may differ according to hormone recep-
tor to defined subtype. Nevertheless, no study has evalu-
ated these associations.
To address these issues, we conducted a large-scale
population-based prospective cohort study in Japan on
the association between green tea intake and the risk of
breast cancer.
Materials and methods
Study population
The Japan Public Health Center-based Prospective Study
(JPHC Study), which began in 1990 for Cohort I and in
1993 for Cohort II, included 140,420 inhabitants (68,722
men and 71,698 women) in the municipalities super-
vised by 11 public health centers (PHC). Details of the
study design have been described elsewhere [19]. Study
participants were informed about the objectives and
methods of the study in written form and those who
responded to the survey questionnaire were regarded as
consenting to participate in the study. In addition, parti-
cipants were also notified in writing that they could
withdraw from the study. Given no relevant ethical
guideline and committee at the time of the survey, the
institutional review board of the National Cancer
Center, Tokyo, Japan considered return of the question-
naire to be classified as informed consent and approved
the study protocol.
The study population comprised registered Japanese
inhabitants living in each PHC area, aged 40 to 59 years
in Cohort I and 40 to 69 years in Cohort II. In the pre-
sent analysis, one PHC area was excluded because data
on cancer incidence were not available. Thus, after
exclusion of ineligible women (n = 98), we defined a
population-based cohort of 67,422 women.
Baseline and five-year follow-up survey
Surveys of the cohort were conducted twice by self-
administered questionnaire, the baseline in 1990 to 1994
and the five-year follow-up in 1995 to 1998. Of 67,422
women, a total of 55,886 women (83%) returned the
baseline questionnaire. Of these, 1,510 who reported a
history of cancer in the baseline survey were excluded,
leaving 54,376 women as the baseline questionnaire
respondents. Of the 67,422 women, we identified 62,788
as eligible for the five-year follow-up survey after exclu-
sion of those who had died, moved out of the study
area, or been lost to follow-up before the survey, of
whom 52,485 (84%) returned the questionnaire. We also
excluded 1,860 women who had a history of cancer at
the five-year follow-up survey and 5,813 women who
did not respond to the baselineq u e s t i o n n a i r e ,l e a v i n g
44,812 women as the five-year follow-up questionnaire
respondents.
Exposure measurements
Information on beverages, including green tea, oolong
tea, black tea, and coffee, was obtained in the baseline
questionnaire in terms of frequency and amount using
six precoded categories: less than one cup per week, one
to two cups per week, three to four cups per week, and
almost daily (further divided into one to two cups per
day, three to four cups per day, and five or more cups
per day). In the five-year follow-up questionnaire, the
consumption of beverages, including two items of green
tea, namely Sencha (first or second flush of green tea;
that is, the first seasonal picking) and Bancha (third or
fourth flush of green tea; that is, the late seasonal pick-
ing)/Genmaicha (blend of bancha and roasted brown
rice), oolong tea, black tea, coffee and canned coffee was
assessed in terms of frequency and amount using nine
precoded categories: less than one cup per week, one to
two cups per week, three to four cups per week, five to
six cups per week, one cup per day, two to three cups
per day, four to six cups per day, seven to nine cups per
day, and ten or more cups per day. Sencha and Bancha
are the two main types of green tea consumed in Japan,
and are usually prepared by steeping the tea leaves in
hot water. The amounts of Sencha or Bancha/
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multiplying the frequency by the portion size for each
beverage (120 ml per cup). Total green tea intake was
defined as the sum of Sencha and Bancha/Genmaicha
intake. The validity of green tea intake reported by the
cohort was assessed using dietary records for 28 days
(seven-day dietary records in four seasons) or 14 days.
Spearman’s correlation coefficients for green tea intake
between the dietary record data and baseline question-
naire were 0.63 for Cohort I [20] and 0.43 for Cohort II
(unpublished data).
Follow-up
All registered women were followed from the start of
the study period to 31 December 2006. Data on residen-
tial relocation were obtained from residential registries.
Among the baseline respondents (n = 54,376), 2,962
w o m e n( 5 . 4 % )m o v e do u to ft h es t u d ya r e aa n d2 0 1
(0.4%) were lost to follow-up. The occurrence of cancer
was identified by active patient notification from major
local hospitals in the study area and data linkage with
population-based cancer registries, with permission from
the local governments responsible for the registries.
Death certificates were used to supplement information
on cancer incidence. Site of origin and histologic type
were coded by members of our Study Group using the
International Classification of Diseases for Oncology,
Third Edition (ICD-O-3), code C500-509. Information
on estrogen receptor (ER) and progesterone receptor
(PR) status was collected from medical records or
pathology reports. Up to the end of the study period,
586 new breast cancer cases were identified among the
baseline questionnaire respondents (n = 54,376) and 362
cases among the five-year follow-up questionnaire
respondents (n = 44,812). Diagnosis was microscopically
verified in 95% of 586 cases, and based on death certifi-
cates only in 1.0%. Information on ER and PR status
was available for 278 (47%) and 262 (45%) of 586 cases,
respectively.
Statistical analysis
Since the assessment of green tea intake differed
between the baseline and five-year follow-up question-
naires, these were analyzed separately. We excluded 583
women with incomplete information for green tea from
54,376 women, leaving a total of 53,793 women, includ-
ing 581 breast cancer cases, for inclusion in the baseline
data analyses. We also excluded 1,173 women with
incomplete information for Sencha or Bancha/Genmai-
cha from 44,812 women, leaving a total of 43,639
women, including 350 breast cancer cases, for inclusion
in the five-year follow-up data analyses.
In the baseline data analyses, person-years of follow-
up were calculated from the baseline survey (1990 to
1994) until the date of diagnosis of breast cancer, date
of relocation from the study area, date of death, or end
of the study period (31 December 2006), whichever
occurred first. Similarly, person-years of follow-up were
calculated from the five-year follow-up survey (1995 to
1998) until the date of diagnosis of breast cancer, date
of relocation from the study area, date of death, or end
of the study period (31 December 2006), whichever
occurred first for the five-year follow-up data analyses.
The Cox proportional hazards model was used to esti-
mate hazard ratio (HR) and 95% confidence intervals
(CI) of breast cancer by green tea intake using the SAS
program (PROC PHREG) (SAS Institute Inc., Cary, NC,
USA). The following variables were used for adjustment
as potential confounders: age, study area, age at
menarche, menopausal status at baseline and age at
menopause, number of births, age at first birth, height,
body mass index, alcohol intake, smoking status, physi-
cal activity, exogenous hormone use, family history of
breast cancer, oolong tea intake, black tea intake, coffee
intake and canned coffee intake. Linear trends for HRs
were tested in the Cox proportional hazards models
using the exposure categories as ordinal variables. All
P-values reported are two-sided, and significance level
was set at P < 0.05.
Results
During 733,667 person-years of follow-up (average fol-
low-up, 13.6 years) for 53,793 women between 1990 to
1994 and 2006, a total of 581 cases of breast cancer
were newly diagnosed and included in the baseline data
analyses; while during 412,801 person-years of follow-up
(average follow-up, 9.5 years) for 43,639 women between
1995 to 1998 and 2006, a total of 350 cases of breast
cancer were newly diagnosed and included in the five-
year follow-up data analyses.
Baseline characteristics of the study participants
according to green tea intake are shown in Table 1.
Approximately 12% of women drank green tea less than
one cup per week while 27% drank five or more cups
per day in the baseline data; and 22% and 30% of
women did not drink Sencha and Bancha/Genmaicha,
while 5.2% and 2.5% drank 10 or more cups per day,
respectively, in the five-year follow-up data. Women
who drank five or more cups per day in the baseline
data tended to be older, live in towns or villages, be tal-
ler, have an earlier onset of first menstruation and fewer
births, have a lower use of exogenous female hormones,
drink less oolong tea and coffee, and consume more
fruits and isoflavones. Similar characteristics was
observed for women who drank 10 or more cups of
Sencha per day in the five-year follow-up data, while
women who drank 10 or more cups of Bancha/Genmai-
cha per day tended to be older, have later onset of first
Iwasaki et al. Breast Cancer Research 2010, 12:R88
http://breast-cancer-research.com/content/12/5/R88
Page 3 of 10Table 1 Baseline characteristics according to green tea intake*
Green tea assessed by baseline
questionnaire
Green tea assessed by five-year
follow-up questionnaire, Sencha
Green tea assessed by five-year
follow-up questionnaire, Bancha/
Genmaicha
Less than
one cup
per week
One to
two cups
per day
Five or
more cups
per day
Less than
one cup
per week
Two to
three cups
per day
Ten or
more cups
per day
Less than
one cup
per week
Two to
three cups
per day
Ten or
more cups
per day
No. of subjects 6,202 11,322 14,308 9,638 9,052 2,281 13,053 8,148 1,099
Age (year), mean 50.4 50.8 53.9 58.2 57.0 58.9 57.5 57.8 59.7
Residential area (town or
village), %
40.9 57.3 68.5 58.7 66.4 73.2 66.9 64.0 60.2
Family history of breast
cancer, %
0.7 1.2 1.1 0.9 1.5 0.8 1.3 1.1 0.9
Premenopausal women,
%
46 47 31 21 24 15 23 22 14
Age at menopause (year),
mean†
49.2 49.3 49.4 - - - - - -
Age at menopause (50 to
54 years old), %
- - - 4 65 04 74 74 94 6
Age at menarche (year),
mean†
15.0 14.6 14.7 15.0 14.6 14.7 14.7 14.7 14.9
Number of births, mean† 2.9 2.7 2.7 3.0 2.6 2.7 2.7 2.7 2.9
Age at first birth (year),
mean†
24.8 25.0 24.9 24.6 25.0 25.0 25.0 24.8 24.6
Use of exogenous female
hormones (current use),
%
1.4 1.0 1.0 2.9 2.4 2.1 2.4 2.3 2.3
Height (cm), mean† 150.9 152.0 152.2 151.1 152.0 152.3 151.8 151.7 151.9
Body mass index (kg/m2),
mean†
23.6 23.3 23.4 23.7 23.3 23.4 23.4 23.4 23.6
Smoking (current
smoker), %
7.9 6.5 7.0 5.6 4.4 8.0 6.1 4.1 8.4
Alcohol drinking (regular
drinker), %
11 14 11 9.7 13 13 13 11 12
Leisure-time physical
activity (≥ once per
week), %
15 18 18 - - - - - -
Physical activity
(metabolic equivalent to
hours per day), mean†
- - - 32.0 31.9 32.2 31.8 32.1 32.4
Vitamin supplement user,
%
20 19 20 12 16 15 15 15 13
Bancha/Genmaicha intake
(≥ four cups per day), %
- - - 30 6.2 25 - - -
Sencha intake (≥ four
cups per day), %
- - - - - - 43 14 44
Oolong tea intake (≥ one
cup per day), %
20 17 10 11 12 8.8 11 13 11
Black tea intake (≥ one
cup per day), %
2.8 5.0 3.2 2.6 5.2 3.8 3.3 5.0 4.4
Coffee intake (≥ one cup
per day), %
41 49 28 36 40 22 34 40 27
Canned coffee intake (≥
one cup per day), %
- - - 4.3 2.7 2.2 2.8 3.2 2.8
Total energy intake (kcal/
day), mean†‡
1,770.0 1,764.0 1,805.2 1,770.1 1,923.5 2,194.0 1,833.9 1,934.6 2,185.8
Fish and shellfish intake
(g/day), mean†‡
105.5 102.8 105.4 79.6 97.5 114.3 88.2 97.0 105.3
Meats intake (g/day),
mean†‡
67.2 65.2 66.1 59.7 60.4 67.7 56.6 61.6 71.6
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ber of births.
We found no inverse association between green tea
intake and the risk of breast cancer regardless of green
t e ai n t a k ea sa s s e s s e db yt h eb a s e l i n eo rf i v e - y e a rf o l -
low-up questionnaire (Table 2). Compared with women
who drank less than one cup of green tea per week, the
adjusted HR for women who drank five or more cups
per day was 1.12 (95% CI 0.81 to 1.56; P for trend =
0.60) in the baseline data analyses. Similarly, compared
with women who drank less than one cup of Sencha or
Bancha/Genmaicha per week, adjusted HRs for women
who drank 10 or more cups per day in the five-year
data analyses were 1.02 (95% CI 0.55 to 1.89; P for
trend = 0.48) for Sencha and 0.86 (0.34 to 2.17; P for
trend = 0.66) for Bancha/Genmaicha.M o r e o v e r ,c o m -
pared with women who drank neither Sencha nor Ban-
cha/Genmaicha, the adjusted HR for women who drank
more than 1,320 ml per day was 1.29 (0.60 to 2.79;
P for trend = 0.70). No substantial change was seen
after further adjustment for other potential confounders
such as residential area or dietary intake of meat, fish,
vegetables, fruit, energy and isoflavones (data not
shown). Further, no substantial change was seen in
either baseline or five-year follow-up data after the
exclusion of women within the first five years of follow-
up to minimize the influence of existing preclinical con-
ditions (data not shown), or after the exclusion of
women who drank more than one cup of oolong tea or
black tea per week to prevent the inclusion of other tea
drinkers into the green tea intake reference category
(data not shown).
To assess the potential influence of changes in green
tea intake during the follow-up period on our findings,
we first categorized subjects into three consumption
groups for each survey: non-drinkers (corresponding to
‘less than one cup per week’), 1 to 719 ml per day, and
more than 720 ml per day (corresponding to ‘more than
five cup per day’ in the baseline questionnaire). We next
categorized subjects into three groups based on the
combination of green tea intake calculated from the
both the baseline and five-year follow-up questionnaires:
non-drinkers for both questionnaires, more than 720 ml
per day for both questionnaires, and other combina-
tions. Compared with women who did not drink green
tea for both questionnaires, adjusted HR was 1.12 (95%
CI 0.45 to 2.83) for women who drank more than 720
ml per day for both questionnaires.
For analysis of cases by hormone receptor status and
among women grouped by menopausal status, we re-
categorized women into four groups for the baseline
data and three for the five-year follow-up data. In the
baseline data analyses, we found no inverse association
between green tea intake and the risk of breast cancer
regardless of hormone receptor-defined subtype (Table 3).
Stratified analyses according to baseline menopausal sta-
t u ss h o w e dn or e m a r k a b l ed i f f e r e n c eb e t w e e ns t r a t a .
Similar results were obtained when we analyzed the
five-year follow-up data (data not shown). Additional
stratified analyses according to dietary intake observed
no remarkable difference between subgroups defined by
dietary isoflavone and folate intake for either the base-
line or five-year follow-up data (data not shown).
In additional analyses to investigate the associations of
oolong tea, black tea, and coffee intake with breast can-
cer risk, we found no inverse associations with the base-
line (Table 4) or five-year follow-up data (data not
shown).
Discussion
In this population-based prospective cohort study, we
found no overall association between green tea intake
and the risk of breast cancer among Japanese women
regardless of menopausal status. Our findings are in
general agreement with those of three prospective stu-
dies, including two Japanese cohort studies, which found
no association between green tea intake and breast can-
cer risk [12-14]. One noteworthy strength of the present
over previous studies is the our remarkably wide varia-
tion in green tea intake, from women who drank green
Table 1 Baseline characteristics according to green tea intake* (Continued)
Vegetable intake (g/day),
mean†‡
293.8 293.7 295.7 217.0 247.7 319.9 234.9 245.8 327.0
Fruit intake (g/day),
mean†‡
175.9 177.3 180.8 208.5 269.9 359.3 243.1 270.1 323.7
Isoflavone intake (mg/
day), mean†‡
31.6 32.2 33.5 37.5 43.3 54.7 41.5 42.0 54.8
* Three categories were chosen from six or nine precoded categories, respectively: less than one cup per week, one to two cups per week, three to four cups per
week, one to two cups per day, three to four cups per day, and five or more cups per day for baseline questionnaire, and less than one cup per week, one to
two cups per week, three to four cups per week, five to six cups per week, one cup per day, two to three cups per day, four to six cups per day, seven to nine
cups per day, and ten or more cups per day for five to year follow-up questionnaire.
†Adjusted for age.
‡ Intake for each subject was estimated from the food frequency questionnaires based on a regression function derived from the validation study data (baseline
questionnaire only).
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Green tea intake assessed by baseline questionnaire
Less than one cup
per week
One to two cups
per week
Three to four cups
per week
One to two cup per
day
Three to four cups
per day
Five or more cups
per day
P for
trend
No. of cases 68 50 36 117 160 150
Person-years 87,841 56,200 40,912 152,896 201,005 194,813
Age- and area-adjusted
HR (95% CI)
1.00 1.18 (0.82 to 1.71) 1.17 (0.78 to 1.75) 1.11 (0.82 to 1.50) 1.18 (0.88 to 1.59) 1.12 (0.83 to 1.51) 0.58
Multivariate HR (95% CI)* 1.00 1.19 (0.80 to 1.76) 1.13 (0.72 to 1.75) 1.13 (0.81 to 1.58) 1.17 (0.85 to 1.62) 1.12 (0.81 to 1.56) 0.60
Green tea intake assessed by five-year follow-up questionnaire
Less than one cup
per week
One to six cups per
week
One cup per day Two to three cups
per day
Four to six cups per
day
Seven to nine cups
per day
Ten or more cups
per day
Pf o r
trend
Sencha
No. of cases 82 56 35 63 78 18 18
Person-years 91,228 75,237 38,328 85,491 73,160 27,641 21,715
Age- and area-adjusted
HR (95% CI)
1.00 0.79 (0.56 to 1.12) 1.02 (0.68 to 1.52) 0.83 (0.59 to 1.16) 1.22 (0.88 to 1.69) 0.74 (0.44 to 1.26) 0.92 (0.55 to 1.55) 0.77
Multivariate HR (95% CI)† 1.00 0.71 (0.46 to 1.08) 0.97 (0.59 to 1.58) 0.85 (0.57 to 1.27) 1.25 (0.84 to 1.86) 0.68 (0.36 to 1.31) 1.02 (0.55 to 1.89) 0.48
Bancha/Genmaicha
No. of cases 107 90 38 69 30 7 9
Person-years 123,189 99,201 42,254 76,532 46,563 14,733 10,329
Age- and area-adjusted
HR (95% CI)
1.00 1.02 (0.77 to 1.36) 1.05 (0.72 to 1.53) 1.09 (0.80 to 1.49) 0.80 (0.53 to 1.21) 0.58 (0.27 to 1.26) 1.02 (0.52 to 2.02) 0.41
Multivariate HR (95% CI)† 1.00 1.12 (0.80 to 1.58) 1.23 (0.79 to 1.92) 1.23 (0.85 to 1.78) 0.83 (0.51 to 1.35) 0.70 (0.28 to 1.76) 0.86 (0.34 to 2.17) 0.66
Total green tea intake assessed by five-year follow-up questionnaire‡
0 1 to 119 ml per day 120 to 299 ml per
day
300 to 599 ml per
day
600 to 959 ml per
day
960 to 1319 ml per
day
1320 ml + per day P for
trend
No. of cases 13 44 48 85 105 28 27
Person-years 18,312 50,715 58,499 91,109 114,255 44,745 35,166
Age- and area-adjusted
HR (95% CI)
1.00 1.25 (0.67 to 2.32) 1.25 (0.67 to 2.32) 1.47 (0.81 to 2.67) 1.48 (0.82 to 2.67) 1.02 (0.52 to 2.00) 1.20 (0.61 to 2.36) 0.88
Multivariate HR (95% CI)§ 1.00 1.08 (0.52 to 2.23) 1.26 (0.62 to 2.56) 1.59 (0.81 to 3.14) 1.43 (0.73 to 2.83) 0.89 (0.40 to 1.97) 1.29 (0.60 to 2.79) 0.70
*,†,§ Adjusted for age (continuous), area (10 public health centers), age at menarche (continuous), menopausal status at baseline (premenopausal women, age at menopause for postmenopausal women (* - 47, 48 to 50, 51 to
53, 54+; †,§ - 44, 45 to 49, 50 to 54, 55+)), number of births (0, 1, 2, 3, 4, 5+), age at first birth (-21, 22 to 25, 26 to 29, 30+, nulliparous), height (continuous), BMI (continuous), alcohol intake (non-drinkers, occasional drinkers,
-150 (g per week) and 150+ (g per week) among regular drinkers (ethanol)), smoking status (never, past, current), *leisure time physical activity (no, one to three days per month, more than one day per week), †,§ daily physical
activity (metabolic equivalent-hours per day) (continuous), exogenous hormone use (never, past, current), family history of breast cancer (yes, no), oolong tea intake (*less than one cup per week, one to four cups per week,
one or more cups per day; †,§ less than 1 cup per week, one to six cups per week, one or more cups per day), black tea intake (*less than one cup per week, one to four cups per week, one or more cups per day; †,§ less than
one cup per week, one to six cups per week, one or more cups per day), coffee intake (*less than one cup per week, one to four cups per week, one to two cups per day, three or more cups per day; †,§ less than one cup per
week, one to six cups per week, one or more cups per day), †,§ canned coffee intake (less than one cup per week, one to six cups per week, one or more cups per day), and †Sencha and Bancha/Genmaicha intake.
Models for Sencha or Bancha/Genmaicha intake did not include these variables, respectively.
‡ Total green tea intake was defined as the sum of Sencha and Bancha/Genmaicha intake (ml per day).
I
w
a
s
a
k
i
e
t
a
l
.
B
r
e
a
s
t
C
a
n
c
e
r
R
e
s
e
a
r
c
h
2
0
1
0
,
1
2
:
R
8
8
h
t
t
p
:
/
/
b
r
e
a
s
t
-
c
a
n
c
e
r
-
r
e
s
e
a
r
c
h
.
c
o
m
/
c
o
n
t
e
n
t
/
1
2
/
5
/
R
8
8
P
a
g
e
6
o
f
1
0tea less than one cup per week to those who drank 10
or more cups per day. This strength argues against the
possibility that the observed absence of associations with
breast cancer risk is attributable to insufficient variation
in green tea intake. Our findings therefore suggest that
green tea intake within a usual drinking habit is unlikely
to reduce the risk of breast cancer.
The other major strength of the present study was its
prospective design, in which information was collected
before the subsequent diagnosis of breast cancer, thereby
avoiding the exposure recall bias inherent to case-control
studies. Subjects were selected from the general popula-
tion, the sample was large, the response rate to the ques-
tionnaire (more than 80%) was acceptable for study
settings such as this, and the loss to follow-up (0.4%) was
negligible. Furthermore, the cancer registry in the study
population was of sufficient quality to reduce the possibi-
lity of misclassification of the outcome.
Several limitations of this study warrant mention. First,
since green tea intake was assessed by self-administered
questionnaire, misclassification may have been unavoid-
able, albeit that our validation study showed relatively
high validity [20]. Changes in green tea intake during the
follow-up period may also have caused misclassification.
To assess the potential influence of this misclassification,
we calculated HRs for women who drank more than 720
ml per day in both the baseline and five-year follow-up
questionnaires versus those who did not drink green tea
in either questionnaire. Although we found no associa-
tion, we cannot deny the possibility that changes in green
tea intake during the follow-up period influenced the
findings, particularly considering that the questionnaires
used in the baseline and five-year follow-up surveys were
different. These misclassifications due to inaccurate mea-
surement would in turn have attenuated the true associa-
tion, which might be one reason for our results.
However, we previously found an inverse association
between green tea intake and the risk of distal gastric
cancer among women [21], and between green tea intake
and the risk of advance prostate cancer among men in
the JPHC study using the same analytic approach, namely
that exposure status was not updated during follow-up
[22]. These findings would also argue against the possibi-
lity that the observed absence of associations with breast
cancer risk was attributable to inaccurate measurement
of green tea intake.
Table 3 Hazard ratio and 95% confidence interval of breast cancer according to subgroup analyses
Green tea intake assessed by baseline questionnaire
Less than one cup per day One to two cups
per day
Three to four cups
per day
Five or more cups
per day
P for trend
All subjects
No. of cases 154 117 160 150
Age- and area-adjusted HR (95% CI) 1.00 1.01 (0.79 to 1.29) 1.08 (0.86 to 1.36) 1.02 (0.81 to 1.30) 0.75
Multivariate HR (95% CI)* 1.00 1.04 (0.80 to 1.35) 1.08 (0.84 to 1.39) 1.03 (0.80 to 1.34) 0.76
ER+PR+ breast cancer
No. of cases 29 25 32 32
Age- and area-adjusted HR (95% CI) 1.00 1.25 (0.73 to 2.17) 1.18 (0.69 to 2.00) 1.05 (0.62 to 1.79) 0.93
Multivariate HR (95% CI)* 1.00 1.33 (0.75 to 2.38) 1.35 (0.77 to 2.36) 1.02 (0.57 to 1.83) 0.92
ER- PR- breast cancer
No. of cases 23 16 20 16
Age- and area-adjusted HR (95% CI) 1.00 1.10 (0.58 to 2.11) 1.09 (0.58 to 2.05) 0.82 (0.42 to 1.60) 0.61
Multivariate HR (95% CI)* 1.00 1.13 (0.55 to 2.32) 1.23 (0.63 to 2.41) 0.81 (0.39 to 1.69) 0.69
Premenopausal women
No. of cases 81 59 71 51
Age- and area-adjusted HR (95% CI) 1.00 1.01 (0.72 to 1.43) 1.13 (0.81 to 1.58) 0.95 (0.66 to 1.37) 0.99
Multivariate HR (95% CI)* 1.00 1.05 (0.73 to 1.49) 1.12 (0.79 to 1.58) 0.97 (0.66 to 1.41) 0.99
Postmenopausal women
No. of cases 70 56 86 96
Age- and area-adjusted HR (95% CI) 1.00 1.01 (0.71 to 1.45) 1.04 (0.75 to 1.45) 1.05 (0.76 to 1.45) 0.76
Multivariate HR (95% CI)* 1.00 1.01 (0.67 to 1.50) 1.02 (0.71 to 1.48) 1.08 (0.75 to 1.55) 0.67
* Adjusted for age (continuous), area (10 public health centers), age at menarche (continuous), menopausal status at baseline (premenopausal women, age at
menopause for postmenopausal women (-47, 48 to 50, 51 to 53, 54+)), number of births (0, 1, 2, 3, 4, 5+), age at first birth (-21, 22 to 25, 26 to 29, 30+,
nulliparous), height (continuous), BMI (continuous), alcohol intake (non-drinkers, occasional drinkers, -150 (g/week) and 150+ (g/week) among regular drinkers
(ethanol)), smoking status (never, past, current), leisure time physical activity (no, one to three days per month, more than one day per week), exogenous
hormone use (never, past, current), family history of breast cancer (yes, no), oolong tea intake (less than one cup per week, one to four cups per week, one or
more cups per day), black tea intake (less than one cup per week, one to four cups per week, one or more cups per day) and coffee intake (less than one cup
per week, one to four cups per week, one to two cups per day, three or more cups per day).
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tion (53,793 women) and long follow-up period (average
13.6 year), the number of breast cancer cases was rela-
tively low (n = 581) in the baseline data analyses, reflect-
ing the low incidence rate in Japan (age-standardized
rate per 100,000 world population in 2002, 32.7 in Japan
and 101.1 in United States for comparison) [23].
Although we found no association between green tea
intake and breast cancer risk (HR for five or more cups
per day versus less than one cup per week = 1.12 in the
baseline data analyses), the 95% CI was 0.81 to 1.56,
which was a relatively wide. Our relatively small sample
size therefore cannot deny the possibility of a smaller
increase or decrease in risk.
Third, although we measured and adjusted for several
potential confounders in the statistical model as far as
possible, the effects of confounding by unmeasured vari-
ables and residual confounding cannot be totally
discarded.
Fourth, information on hormone receptor status was
available for 45 to 47% cases in the present study. The
major reason for the unknown cases is that collection of
this information began in 2002, while data for 1990 to
2002 were obtained by retrospective review of medical
records or pathology reports. The relatively small num-
ber of cases weakened the statistical power to detect the
association. In addition, despite the generally high agree-
ment between the enzyme-linked immunoassay and
immunohistochemical techniques, differences in classifi-
cation as well as interlaboratory variation may result in
misclassification, which, if present, may have also atte-
nuated the true association. These methodological lim-
itations might partly explain our findings, which showed
no inverse association between green tea intake and the
risk of breast cancer regardless of hormone receptor-
defined subtype. Thus, further research to clarify the dif-
ferential associations by hormone receptor-defined sub-
type is warranted.
Our findings contradict those of three case-control
studies, which showed an inverse association [9-11].
Given that all three previous prospective studies showed
no association [12-14], these findings might have been
influenced by recall and selection bias stemming
from the case-control design. Meanwhile, for the three
Table 4 Hazard ratio and 95% confidence interval of breast cancer according to oolong tea, black tea and coffee
intake as assessed by baseline survey
Oolong tea intake
Less than one cup per week One to four cups
per week
One or more cups
per day
P for trend
No. of cases 336 153 76
Person-years 454,964 148,821 93,630
Age- and area-adjusted HR (95% CI) 1.00 1.37 (1.13 to 1.67) 1.09 (0.85 to 1.41) 0.08
Multivariate HR (95% CI)* 1.00 1.34 (1.09 to 1.66) 0.98 (0.74 to 1.30) 0.40
Black tea intake
Less than one cup per week One to four cups
per week
One or more cups
per day
P for trend
No. of cases 441 111 24
Person-years 557,038 140,312 24,776
Age- and area-adjusted HR (95% CI) 1.00 1.00 (0.81 to 1.24) 1.29 (0.85 to 1.96) 0.45
Multivariate HR (95% CI)* 1.00 0.84 (0.67 to 1.07) 1.30 (0.84 to 2.02) 0.80
Coffee intake
Less than one cup per week One to four cups
per week
One to two cups
per day
Three or more
cups per day
P for trend
No. of cases 161 180 173 63
Person-years 233,697 213,979 210,969 69,940
Age- and area-adjusted HR (95% CI) 1.00 1.20 (0.97 to 1.49) 1.18 (0.94 to 1.48) 1.30 (0.95 to 1.77) 0.09
Multivariate HR (95% CI)* 1.00 1.15 (0.91 to 1.46) 1.12 (0.87 to 1.43) 1.22 (0.87 to 1.71) 0.26
* Adjusted for age (continuous), area (10 public health centers), age at menarche (continuous), menopausal status at baseline (premenopausal women, age at
menopause for postmenopausal women (-47, 48 to 50, 51 to 53, 54+)), number of births (0, 1, 2, 3, 4, 5+), age at first birth (-21, 22 to 25, 26 to 29, 30+,
nulliparous), height (continuous), BMI (continuous), alcohol intake (non-drinkers, occasional drinkers, -150 (g/week) and 150+ (g/week) among regular drinkers
(ethanol)), smoking status (never, past, current), leisure time physical activity (no, one to three days per month, more than one day per week), exogenous
hormone use (never, past, current), family history of breast cancer (yes, no), green tea intake (less than one cup per day, one to two cups per day, three to four
cups per day, five or more cups per day), oolong tea intake (less than one cup per week, one to four cups per week, one or more cups per day), black tea intake
(less than one cup per week, one to four cups per week, one or more cups per day) and coffee intake (less than one cup per week, one to four cups per week,
one to two cups per day, three or more cups per day). Models for oolong tea, black tea, or coffee intake did not include these variables, respectively.
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Page 8 of 10case-control studies conducted outside Japan [9-11],
inconsistent findings might be in part explained by dif-
ferences in the type of green tea and drinking method.
In general, green tea contains catechins, minerals, and
vitamins, and their contents vary among green tea types:
Sencha, for example, one of most popular green teas in
Japan, contains higher levels of tannin, vitamin C and
folate than Bancha/Genmaicha [24]. The present study,
however, found no overall association between green tea
intake and the risk of breast cancer regardless of type.
Moreover, levels of tea polyphenol and other nutrients
in green tea varies according to preparation, amount of
green tea leaves, frequency of renewing a tea batch in
the pot, water temperature, brewing time, and so on.
Although two Chinese case-control studies took account
of several of these conditions, including green tea leaf
amount, brew strength, and tea batch renewal frequency
[9,10], no study has directly measured prediagnostic bio-
markers of tea polyphenols. In this regard, we con-
ducted a nested cased-control study within the JPHC
study and found no overall association between plasma
tea polyphenols and the risk of breast cancer [25]. Dif-
ferences in tea polyphenols level due to green tea type
and drinking method are therefore unlikely to explain
these inconsistent findings, in any major way at least.
Alternatively, the inconsistencies reported in previous
studies might be explained by possible effect modifica-
tion by dietary factors and genetic polymorphisms
[11,14,26]. In a case-control study in Asian-Americans, a
risk-reducing effect of green tea was primarily observed
among subjects whose soy intake was low [11], while a
nested case-control study in Singapore showed a protec-
tive effect of green tea against breast cancer among
women with high-activity genotypes of the methylenete-
trahydrofolate reductase (MTHFR)a n dthymidylate
synthase (TYMS) genes [14]. This association was stron-
ger among those whose dietary folate intake was low.
Subsequent studies, including our present study, how-
ever, have failed to replicate effect modification by soy
and folate intake [9,13]. On the other hand, given a lack
of information on genetic polymorphisms, the possibility
cannot be excluded that green tea drinking is protective
among subgroups of women.
Moreover, a recent cohort study in Shanghai showed a
time-dependent interaction between green tea consump-
tion and age of breast cancer onset: HRs for women
who started green tea drinking at 25 years of age or
younger versus non-green tea drinkers were 0.69 for
premenopausal breast cancer and 1.61 for postmenopau-
sal breast cancer [16]. This complex observation might
also provide an explanation for the inconsistencies
reported in previous studies. However, the present study
was not able to examine time-dependent interactions
because of a lack of information on green tea drinking
habits, such as age at the beginning of green tea drink-
ing and years of drinking.
Although oolong tea, black tea, and coffee are less popu-
lar than green tea in Japan, they are also rich in phenolic
compounds and have been hypothesized to have a protec-
tive effect against the development of breast cancer:
oolong tea and black tea contain higher levels of theafla-
vins and thearubigins than catechins, and coffee contains a
high level of chlorogenic acid [1-3]. We also found no
association of oolong tea, black tea, coffee and canned cof-
fee intake with breast cancer risk. In addition to the rela-
tively small number of women who drank oolong tea,
black tea, and coffee, the potential influence of green tea
intake on our findings was not fully excluded, albeit that
we adjusted for green tea intake. Our findings for black
tea, however, are consistent with those of a previous meta-
analysis [27]. In contrast, our findings for coffee intake
contradict a recent meta-analysis, which suggested a small
risk-reducing effect of coffee intake on breast cancer: for
example, relative risk (95% CI) per increment of two cups
per day was 0.98 (0.96 to 1.00) based on 18 studies [28]. In
addition to this small risk reduction, the small variation in
coffee intake in our participants might have contributed in
part to our findings.
Conclusions
In this population-based prospective cohort study, we
found no overall association between green tea intake
and the risk of breast cancer among Japanese women.
Our findings suggest that drinking green tea as a bever-
age is unlikely to reduce the risk of breast cancer
regardless of green tea type and number of cups within
a usual drinking habit.
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